The Philadelphia-based insurer is the first Blue Cross Blue Shield plan to cover the ConfirmMDx for Prostate Cancer test.
“This positive coverage decision by Independence Blue Cross is a significant milestone as we work toward achieving nationwide payer adoption of our ConfirmMDx for Prostate Cancer test,” said Jan Groen, PhD, CEO of MDxHealth. “This decision demonstrates that our investment in clinical studies and our work with managed care organizations in the U.S. continues to yield positive results.”
More articles about payer issues:
BCBS of Texas commits to offering ACA plans for 2017
House will vote on ACA individual mandate exemption bill
Aetna looks toward social programs for healthcare reform
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
